Navigation Links
hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate

ProductshKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
Company Upstate
Item hKvLQT1/hminK-CHO K1 Recombinant Cell Line
Price 
Description PrecisION Ion Channel Cell Lines
High Quality, Functionally-Validated, Ion Channel Cell Lines

Ion channels are well known for having a critical role in nerve and muscle function and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression.

Historically, ion channels have been under exploited as drug targets primarily due to the lack of functional high throughput screening technologies. Over recent years, there has been considerable progress in this important area. However, now there is a requirement for high quality research tools that will allow the full benefit of the new screening technologies to be realised. Upstate has built a portfolio of ion channel cell lines to meet these new and evolving needs in the drug discovery industry.

Our ion channel cell lines are available off of the shelf. These cell lines are fully validated using electrophysiology, stable (>25 passage) and licensed for drug discovery research. The objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions.
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
2. Recombinant RNasin® Ribonuclease Inhibitor from Promega
3. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
4. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
5. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
6. hERG-CHO K1 Recombinant Cell Line from Upstate
7. hERG-CHO K1 Recombinant Cell Line from Upstate
8. hHCN4-CHO K1 Recombinant Cell Line from Upstate
9. hKv1.5-CHO K1 Recombinant Cell Line from Upstate
10. hNav1.6-HEK293 Recombinant Cell Line from Upstate
11. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
SHEEP ANTI DEHYDROEPIANDROSTERONE...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure Grade DAPI is greater than or equal to 98% pure by HPLC....
... Smith et.al. (1997) • Contains ... current biochemistry & molecular biology, ... headwords. Entries give details of ... in which they are involved ...
... B.S. Dunbar (1994) • This book ... and methods for preparing samples for ... as radiometric and bioluminescence-enhanced detection systems ... are, the detection and characterization of ...
Biology Products:
(Date:6/11/2020)... SEABROOK, N.H. (PRWEB) , ... June 09, 2020 , ... ... integrator of custom industrial automation and IT solutions for the life sciences industry, is ... President of Business Development working out of the company’s Seabrook, New Hampshire office. ...
(Date:6/5/2020)... ... 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company based ... understands the need for a global perspective to make an impact in a post ... will serve as an independent, director of the company. , “The Greffex board is ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer ... Critical Environments Group (CEG) to market and sell its complete line of biometric ... IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... , ... July 16, 2020 , ... After research model ... completion of a great surgery is only the beginning of a successful study, while ... community. , Join Brad Gien, Global Head of Surgery from Envigo in ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive ... PathSensors to move into the point-of-care diagnostic market, focusing initially on the ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... therapy for treating cancer, today announced the company has entered a license agreement ... The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding ...
Breaking Biology Technology: